Analysis of the Prevalence and Types of Adverse Drug Reactions
DOI:
https://doi.org/10.52692/1857-0011.2024.2-79.07Keywords:
pharmacovigilance, medicinal drugs, adverse reactionsAbstract
Pharmacovigilance, which monitors adverse drug reactions (ADRs), plays a crucial role in ensuring patient safety within healthcare facilities. This study analyzes ADRs recorded in the inpatient departments of the Scientific Research Institute of Lung Diseases under the Ministry of Health of the Republic of Azerbaijan over a two-year period (2022- 2024). The data collection covers various drugs and documents the nature and frequency of observed adverse effects.The aim of this study is to identify the most common ADRs, determine high-risk drugs, and understand patterns of specific adverse effects, providing valuable insights for medical personnel and playing an important role in enhancing patient safety.
References
Centers for Disease Control and Prevention (CDC). “Managing Drug Interactions in the Treatment of HIV- Related Tuberculosis.” 2013.
European Medicines Agency (EMA). “Pharmacovigilance: Overview.”
Moore, N., Berdaï, D., Blin, P., Droz, C. Pharmacovigilance – The Next Chapter. Therapie, 2019; 74(6):557-567.
Saukkonen, J.J., Cohn, D.L., Jasmer, R.M., etal. An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy. American Journal of Respiratory and Critical Care Medicine, 2006; 174(8):935-952.
South African Health Products Regulatory Authority (SAHPRA). “Guideline for Adverse Drug Reactions (ADRs) Reporting for Healthcare Professionals.” 2020.
Tostmann, A., Boeree, M.J., Aarnoutse, R.E., et al. Antituberculosis Drug-Induced Hepatotoxicity: Concise Up-to-Date Review.” Journal of Gastroenterology and Hepatology, 2008; 23(2):192-202.
World Health Organization (WHO). “Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions.” 2018.
World Health Organization (WHO). “Treatment of Tuberculosis: Guidelines.” 2022.
Зырянов С.К., Белоусов Ю.Б. Организация и развитие службы фармаконадзора Фарматека. 2005. № 16. c. 13–18.
Лепахин В.К., Стуров Н.В., Астахова А.В. Методы выявления и регистрации неблагоприятных побочных реакций на лекарственные средства в период их широкого применения. Трудный пациент. 2008, сентябрь. – c. 52–56.
Овчинникова Е.А. Анализ систем мониторинга побочных реакций в разных странах мира. Вестник Российской академии медицинских наук.2014. № 2. c. 50–55.
Воронина Н.В., Упницкий А.А. Побочные эффекты лекарственных средств и методы их выявления. Лечебное дело. 2007. № 8. c. 45–49.
Downloads
Published
License
Copyright (c) 2025 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
